Manufacturing “Hub-and-spoke” drug manufacturing set to benefit from new FDA rule Pharmaceutical TechnologyThe proposed rule would allow multiple manufacturing units at different locations to register as one establishment.Read full story pharminent July 13, 2026 (Last updated: July 15, 2026) Pharmaceutical Technology The proposed rule would allow multiple manufacturing units at different locations to register as one establishment. Read full story Post navigation Previous: FDA approves MSD’s Keytruda combinations for MIBCNext: FDA posts new rejection letters days after confirming pause Related Stories Manufacturing Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision pharminent September 9, 2026 Manufacturing US puts $125m into personalised RNA therapy production pharminent September 2, 2026 Manufacturing Multispecifics are transforming the CDMO development architecture pharminent August 28, 2026